Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mind Cure Health Inc (OP:MCURF)

N/A UNCHANGED
Last Price Updated: 2:36 PM EDT, Sep 11, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Cure Health Inc

< Previous 1 2 3 Next >
News headline image
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies ↗
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o... 
Via Benzinga
News headline image
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More ↗
Institutional analysts are taking a liking to the industry ... 
Via Benzinga
News headline image
Professional Sports Turn To Psychedelics ↗
Psychedelic drug R&D is rapidly expanding into many of the largest medical treatment markets. 
Via Talk Markets
News headline image
Why Smaller Psychedelics Companies Should Start Catching Up To The Sector Leaders ↗
Concentration of ownership in psychedelic drug stocks has reached a new extreme. We explain how and why we don't see this trend as being sustainable. 
Via Talk Markets
Psychedelics As A Potential Form Of Treatment For Traumatic Brain Injuries ↗
In recent years, there has been a re-emergence in the study of psychedelic drug... 
Via Benzinga
News headline image
The Next Psychedelic Stock To Uplist On The Nasdaq? ↗
As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next? 
Via Talk Markets
News headline image
Second-Chance Buying Opportunity With Psychedelic Stock Warrants ↗
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive. 
Via Talk Markets
News headline image
Déjà Vu: 2021 Slump In Psychedelic Stocks Mirrors 2020 ↗
Charts for most psychedelic drug stocks look terrible in recent weeks. The same was true in the summer of 2020 -- immediately before these stocks exploded higher. Deja vu? 
Via Talk Markets
Psychedelic Drugs Market Size Is Projected To Reach $10.75 Billion By 2027
Via FinancialNewsMedia
MINDCURE Partners its iSTRYM Technology with LUCID to Discover and Create Proprietary Music Experiences for Use During Psychedelic-Assisted Therapy Sessions
Via FinancialNewsMedia
Topics Artificial Intelligence
Cannabis Movers & Shakers: TILT, BRNT, ECGI, Alcanna, WeedMD, Mind Cure, Flowr Corporation, VIVO, Cannabiz, Team Hytiva ↗
TILT Holdings Announces Two New Additions To Its Leadership Team TILT Holdings Inc. (CSE: 
Via Benzinga
Topics Cannabis
Psyched: Entheon Launches Psychedelics Genetic Test, Mydecine Unveils Psychedelic Drug Candidates, California Bill Passes Senate Committee ↗
Entheon Biomedical Corp. announced the 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.